SAMDI Tech Expands Small Molecule Compound Libraries Through Partnership with Enamine

08:00 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has partnered with Enamine, the world's largest supplier of drug-like screening compounds, to expand the number of molecules in t...

Other Sources for this Article

SCORR Marketing for SAMDI Tech, Inc.
Lea Studer, 308-237-5567


More From BioPortfolio on "SAMDI Tech Expands Small Molecule Compound Libraries Through Partnership with Enamine"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...